IP78-11: Efficacy of Selective Renal Tumor Embolization Combined with Axitinib and Reduced-Dose Toripalimab in Oligometastatic Clear Cell Renal Carcinoma: An Updated Analysiswith Patient-Derived Organoid and Immune Co-culture Insights.

IP78-11: Efficacy of Selective Renal Tumor Embolization Combined with Axitinib and Reduced-Dose Toripalimab in Oligometastatic Clear Cell Renal Carcinoma: An Updated Analysiswith Patient-Derived Organoid and Immune Co-culture Insights.

Monday, May 18, 2026 7:00 AM to 9:00 AM · 1 hr. 59 min. (America/New_York)
147B
Abstract

Speakers

JD
Jun Du

Log in

See all the content and easy-to-use features by logging in or registering!